CD39 Emerges as a Deadly Biomarker and Drug Target in Bile Duct Cancer
New research shows that the immune enzyme CD39 is overexpressed in cholangiocarcinoma, drives tumor growth and metastasis through the ANXA2 ...
Tag: Cholangiocarcinoma biomarker
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!